Delivery Order SPE2DB22D2006-SPE2DB25FW2WC
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $126,953.03 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply deliveries to support federal healthcare operations. This firm fixed price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of July 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award was made through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for an estimated value of $126,811.82 under a firm fixed-price contract structure. This non-competed delivery order, with an ultimate completion date of July 21, 2025, represents a procurement of pharmaceutical products and medical supplies to support federal military and healthcare operations. The work will be performed at the contractor's Corporate Office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,324.08 to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, issued without set-aside restrictions, represents a competitively awarded contract for pharmaceutical products and medical supplies supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,889.23 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $2,957.22 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,403.30 to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, on August 4, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by August 5, 2025. The award was made through competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $22,443.00 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger vehicle, specifically the DLA Troop Support Medical Indefinite Delivery...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2WCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,099.05 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of pharmaceutical products, specifically 700 rolls of a 1.25" x 4" item (SKU: 4568898321) packaged in 6-roll boxes. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries under the SPE2DX IDC, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The broader DLA Troop Support Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to make multiple awards to separate regional contractors, underscoring AmerisourceBergen's strategic role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |